Adverse effects during the whole study period in 18 patients with CSS treated with a “standard” prednisone/cyclophosphamide treatment with (treatment group) or without (control group) IVIg synchronised with PP
| Treatment group (n = 9) | Control group (n = 9) | |
|---|---|---|
| *p<0.057, Fisher’s exact test. | ||
| Steroid related | ||
| Osteoporosis | 3 | 8* |
| Diabetes | 2 | 3 |
| Arterial hypertension | 2 | 4 |
| Myopathy | 1 | 2 |
| Cushingoid habitus | 1 | 1 |
| Cyclophosphamide related | ||
| Hypogammaglobulinaemia | 0 | 2 |
| Permanent lymphopenia | 1 | 1 |
| Bacterial pneumonia | 1 | 2 |